Early Phase 1 Genetic Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Diffuse Large B Cell LymphomaB-ALLDLBCL Unclassifiable+7 more

Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT04512716

Recruiting

Early Phase 1

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

Androgenetic alopecia (AGA)

Shanghai Zhongshan Hospital30 enrolled1 locationNCT07012486